SEC Form 4 · accession 0001292445-15-000002
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Breckon
Director
Period of report
May 7, 2015
Accepted (ET)
May 11, 2015 · 8:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | May 7, 2015 | S | 4,145 | $29.68 | D | 13,607 | D | |
| Class A Common Stock | May 7, 2015 | M | 5,526 | $8.45 | A | 19,133 | D | |
| Class A Common StockF2 | May 7, 2015 | F | 1,445 | $32.33 | D | 17,688 | D | |
| Class A Common StockF1 | May 7, 2015 | S | 4,081 | $29.68 | D | 13,607 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $8.45 | May 7, 2015 | M | 5,526 | D | — | Sep 28, 2020 | Class A Common Stock | 5,526 | 12,225 | D |
Explanation of responses
- F1The price represents the public offering price of $31.00 per share of Common Stock, par value $0.01 per share (each, a "Share"), of INC Research Holdings, Inc. (the "Issuer"), less the underwriting discount of $1.32 per Share.
- F2Pursuant to the Issuer's 2010 Equity Incentive Plan, this is the fair market value based on a 20-day average of the closing prices of the Issuer's common stock for purposes of cancellation of shares to pay the exercise price and withholding taxes.
- F3The shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued service on the Issuer's Board of Directors.